Dana Investment Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Dana Investment Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-7,166	Closed	-$1.17M	–	278
2014 Q4	$1.17M	Buy	7,166 +877	+14%	+$146K	0.05%	165
2014 Q3	$1.01M	Sell	6,289 -4,321	-41%	-$664K	0.06%	168
2014 Q2	$1.56M	Buy	10,610 +564	+6%	+$78.2K	0.09%	131
2014 Q1	$1.39M	Sell	10,046 -7,094	-41%	-$1.07M	0.09%	136
2013 Q4	$2.17M	Sell	17,140 -8,855	-34%	-$916K	0.14%	122
2013 Q3	$2.39M	Sell	25,995 -1,887	-7%	-$152K	0.17%	102
2013 Q2	$1.92M	Buy	+27,882	New	+$1.7M	0.15%	116

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

WBC

Westpac Banking Corp Sydney, Australia $1.44B AUM 28.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dana Investment Advisors's JAZZ Position: Q1 2015 in Review

Dana Investment Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2015, closing a stake of 7,166 shares — an estimated $1.17M sold.

Dana Investment Advisors first reported a position in JAZZ in Q2 2013 and held it in 7 quarters. The position peaked at $2.39M in Q3 2013. 354 funds tracked by Wall St. Rank hold JAZZ as of Q1 2015.

Dana Investment Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Dana Investment Advisors sold 7,166 Jazz Pharmaceuticals shares in Q1 2015, an estimated $1.17M.
Dana Investment Advisors first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 7 quarters.
Dana Investment Advisors's Jazz Pharmaceuticals position peaked at $2.39M in Q3 2013.
354 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2015.

Based on Dana Investment Advisors's 13F filing for Q1 2015, filed 15 May 2015.